Cough
📧 Sign up to get email alerts when something new happens for Cough.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Cough Reflex Sensitivity and Bronchial Hyper-responsiveness
A Mayo Clinic-sponsored clinical trial evaluating cough reflex sensitivity and bronchial hyper-responsiveness in patients with gastroesophag…
-
FDA approval · 2017-02-13FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Original Application (Novel Laboratories, Inc.)
FDA approved Novel Laboratories, Inc.'s generic hydrocodone bitartrate and homatropine methylbromide tablets (Original Application) for coug…
-
FDA approval · 2017-01-13FDA Approved: PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' supplemental application for promethazine hydrochloride and codeine phosphate, a generic combination p…
-
FDA approval · 2016-12-15FDA Approved: HYDROMET — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for HYDROMET (hydrocodone bitartrate and homatropine methylbromide) from Actavis Pharma.
-
FDA approval · 2016-09-20FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE — Original Application (Acella Pharmaceuticals, LLC)
FDA approved an original application for a generic combination product containing brompheniramine maleate, pseudoephedrine hydrochloride, an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-08-25FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)
FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) from Mainpointe Pharmaceuticals. The ap…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial [NA]
This completed randomized, double-blind, placebo-controlled trial from Yonsei University evaluated the efficacy of a proton pump inhibitor f…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Effect of Electronic Cigarette Use on Cough Reflex Sensitivity [Phase 4]
A Phase 4 clinical trial investigating how electronic cigarette use affects cough reflex sensitivity has been completed with results posted …
-
CLINICAL_TRIALS research · 2016-03-22Clinical Trial Update: Predictive Factors in Response to Inhaled Corticoids in Chronic Cough [NA]
This clinical trial update reports on a study investigating predictive factors for response to inhaled corticosteroids in chronic cough.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Treatment of Refractory Chronic Cough With PA101 [Phase 2]
Phase 2 study of PA101 for refractory chronic cough has completed. The snippet does not include trial results.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: An Open Label Trial of Azithromycin in Chronic Productive Cough [Phase 3]
Open-label Phase 3 trial evaluating azithromycin for chronic productive cough; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children. [Phase 4]
A phase 4 trial comparing two cough syrups for cough due to cold in children; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough [Phase 2]
A Phase 2 randomized trial evaluated the efficacy and safety of Ivy Leaves Cough Liquid versus placebo for acute cough; the study has comple…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating the efficacy and safety of SCH 486757 in adults with chronic cough.
-
FDA approval · 2015-07-31FDA Approved: BENZONATATE — Original Application (TAGI Pharma, Inc.)
The FDA approved TAGI Pharma, Inc.'s original application for benzonatate, establishing the availability of this generic cough suppressant.
-
FDA approval · 2015-07-30FDA Approved: BENZONATATE — Original Application (Strides Pharma Science Limited)
FDA approves Strides Pharma Science Limited's generic Benzonatate through an Original Application (ANDA) for relief of cough.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo [Phase 4]
Phase 4 trial evaluating the antitussive effect of a naturally flavored syrup containing diphenhydramine, compared with dextromethorphan and…
-
EMA guidance · 2015-04-24Codeine not to be used in children below 12 years for cough and cold
The EMA advises that codeine should not be used in children under 12 years for cough and cold.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin [Phase 1]
A Phase 1 single-dose trial of an extended-release combination tablet of codeine and guaifenesin has been completed.
-
EMA guidance · 2015-03-13PRAC recommends restrictions on the use of codeine for cough and cold in children
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommends restricting codeine use for cough and cold in children due to safety…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Respiratory Kinematics During Voluntary and Reflex Cough in Healthy Adults [Phase 1, Phase 2]
Clinical trial updates on respiratory kinematics during voluntary and reflex cough in healthy adults (Phase 1/Phase 2) completed with posted…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough [Phase 2]
The Phase 2 exploratory study of FP01 lozenges in chronic refractory cough has completed.
-
CLINICAL_TRIALS research · 2014-09-01Clinical Trial Update: French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL) [NA]
This clinical trial update reports on the French linguistic and metric validation of the parent-proxy Chronic Cough-specific QoL questionnai…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection [Phase 2]
Phase 2 trial evaluating the antitussive effects of FP01 lozenges in subjects with cough due to upper respiratory tract infection has been c…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888) [Phase 2]
A Phase 2 clinical trial evaluating SCH 619734 for chronic cough of unknown origin has completed, assessing its efficacy and safety.